Activate Immunotherapy Terminates Financing Agreement

/EINPresswire.com/ -- Activate Immunotherapy today announced that the financing agreement with NovaRx has been terminated by mutual agreement.

Activate Immunotherapy will be dissolved and wound up.

CONTACT:
Dr. Stella M. Sung,
Chief Business Officer
Activate Immunotherapy
ssung@activateimmunotherapy.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Activate Immunotherapy Terminates Financing Agreement

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.